1. |
DeSantis CE, Fedewa SA, Goding Sauer A,et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin, 2016, 66(1): 31-42.
|
2. |
Fan L, Strasser-Weippl K, Li JJ,et al. Breast cancer in China. Lancet Oncol, 2014, 15(7): e279-e289.
|
3. |
Ma CD, Zhou Q, Nie XQ,et al. Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patterns. Crit Rev Oncol Hematol, 2009, 71(3) : 258-265.
|
4. |
Schonberg MA, Marcantonio ER, Li D,et al. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol, 2010, 28(12): 2038-2045.
|
5. |
Griffith KA, Sabel MS, Newman LA,et al. The elderly breast cancer patient: Association of age, tumor size, and grade with sentinel lymph node status. J Clin Oncol, 2012, 30(27_Suppl): 15.
|
6. |
Grumpelt AM, Ignatov A, Tchaikovski SN,et al. Tumor characteristics and therapy of elderly patients with breast cancer. J Cancer Res Clinl Oncol, 2016, 142(5): 1109-1116.
|
7. |
de Munck L, Schaapveld M, Siesling S,et al. Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands. Breast Cancer Res Treat, 2011, 129(1): 229-233.
|
8. |
Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst, 2000, 92(7): 550-556.
|
9. |
韩颖. 老年乳腺癌的特点及其化学治疗策略. 癌症进展, 2014, 12(3): 233-237.
|
10. |
赵卫红, 徐兵河, 李青, 等. 70岁以上老年女性乳腺癌患者的特点和预后分析. 中华肿瘤杂志, 2006, 28(5): 385-388.
|
11. |
Vetter M, Huang DJ, Bosshard G,et al. Breast cancer in women 80 years of age and older: a comprehensive analysis of an underre-ported entity. Acta Oncol, 2013, 52(1): 57-65.
|
12. |
Ali AM, Greenberg D, Wishart GC,et al. Patient and tumor characteristics,management, and age-specific survival in women with breast cancer in the East of England. Br J Cancer, 2011, 104(4): 564-570.
|
13. |
卢晓红. 青、老年乳腺癌淋巴结转移规律的分析. 中国肿瘤临床与康复, 2002, 9(6): 85-86.
|
14. |
Biganzoli L, Wildiers H, Oakman C,et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol, 2012, 13(4): e148-e160.
|
15. |
Martelli G, Miceli R, Daidone MG,et al. Axillary dissectionversus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol, 2011, 18(1): 125-133.
|
16. |
Giuliano AE, Hunt KK, Ballman KV,et al. Axillary dissectionvs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA, 2011, 305(6): 569-575.
|
17. |
Chen J, Zhang C, Li F,et al. A meta-analysis of clinical trials assessing the effect of radiofrequency ablation for breast cancer. Onco Targets Ther, 2016, 9: 1759-1766.
|
18. |
Palussière J, Henriques C, Mauriac L,et al. Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomes. Radiology, 2012, 264(2): 597-605.
|
19. |
Susini T, Nori J, Olivieri S,et al. Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol Oncol, 2006, 104(2): 304-310.
|
20. |
Coombes RC, Kilburn LS, Snowdon CF,et al. Survival and safety of exemestaneversus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet, 2007, 369(9561): 559-570.
|
21. |
Kaufmann M, Jonat W, Hilfrich J,et al. Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study. J Clin Oncol, 2007, 25(19): 2664-2670.
|
22. |
Morgan J, Wyld L, Collins KA,et al. Surgeryversus primary endocrine therapy for operableprimary breast cancer in elderly women (70 years plus). The Cochrane Library, Published Online: 16 MAY 2014,.
|
23. |
National Comprehensive Cancer Network. (NCCN) Clinical Practice Guidelines in Oncology. Breast cancer, Version 2. , 2016-05-16.
|
24. |
Hughes KS, Schnaper LA, Bellon JR,et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. J Clin Oncol, 2013, 31(19): 2382-2387.
|
25. |
Giordano SH, Duan Z, Kuo YF,et al. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol, 2006, 24(18): 2750-2756.
|
26. |
Muss HB, Berry DA, Cirrincione CT,et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med, 2009, 360(20): 2055-2065.
|
27. |
Pinder MC, Duan Z, Goodwin JS,et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol, 2007, 25(25): 3808-3815.
|
28. |
Du XL, Xia R, Liu CC,et al. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer. Cancer, 2009, 115(22): 5296-5308.
|
29. |
Hershman DL, McBride RB, Eisenberger A,et al. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. J Clin Oncol, 2008, 26(19): 3159-3165.
|
30. |
Miles D, Baselga J, Amadori D,et al. Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase Ⅲ trial (CLEOPATRA). Breast Cancer Res Treat, 2013, 142(1): 89-99.
|
31. |
Chavez-MacGregor M, Zhang N, Buchholz TA,et al. Tras-tuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol, 2013, 31(33): 4222-4228.
|
32. |
Pritchard KI, Burris HA 3rd, Ito Y,et al. Safety and efficacy of everolimus with exemestanevs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2. Clin Breast Cancer, 2013, 13(6): 421-432.
|
33. |
Ragaz J, Jackson SM, Le N,et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med, 1997, 337(14): 956-962.
|
34. |
Overgaard M, Hansen PS, Overgaard J,et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med, 1997, 337(14): 949-955.
|
35. |
Harris JR, Halpin-Murphy P, McNeese M,et al. Consensus Statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys, 1999, 44(5): 989-990.
|
36. |
Recht A, Edge SB, Solin LJ,et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol, 2001, 19(5): 1539-1569.
|
37. |
National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst Monogr, 2001, 30: 5-15.
|
38. |
Smith BD, Haffty BG, Hurria A,et al. Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol, 2006, 24(30): 4901-4907.
|
39. |
Truong PT, Lee J, Kader HA,et al. Locoregional recurrence risks in elderly cancer patients treated with mastectomy without adjuvant radiotherapy. Eur J Cancer, 2005, 41(9): 1267-1277.
|
40. |
Hughes KS, Schnaper LA, Bellon JR,et al . Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol, 2013, 31(19): 2382-2387.
|
41. |
Fyles AW, McCready DR, Manchul LA,et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med, 2004, 351(10): 963-970.
|
42. |
Smith BD, Haffy BG, Buchholz TA,et al. Effevtiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst, 2006, 98(18): 1302-1310.
|
43. |
Truong PT, Bernstein V, Lesperance M,et al. Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg, 2006, 191(6): 749-755.
|
44. |
Martelli G, Boracchi P, Guzzetti E,et al. Omission of radiotherapy in elderly patients with early breast cancer: 15-Year results of a prospective non-randomised trial. Eur J Cancer, 2015, 51(11): 1358-1364.
|
45. |
Bastiaannet E, Liefers GJ, de Craen AJ,et al. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127 805 unselected patients. Breast Cancer Res Treat, 2010, 124(3): 801-807.
|
46. |
Patnaik JL, Byers T, Diguiseppi C,et al. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst, 2011, 103(14): 1101-1111.
|
47. |
Schonberg MA, Marcantonio ER, Ngo L,et al. Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol, 2011, 29(12): 1570-1577.
|